ArticleThe Journal of biological chemistry

Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET.

Joost Neijssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.